T1	Participants 423 556	Thirty-five healthy adults age 35-69 years were enrolled in a randomized, double-blind, placebo-controlled trial of 8 weeks' duration
T2	Participants 621 659	Nineteen participants received gelcaps
T3	Participants 749 781	16 participants received gelcaps
